about
Oxygen therapy for acute myocardial infarctionMammario-arterial anastomosis versus aorto-arterial anastomosis as proximal anastomotic sites in coronary artery bypass surgery for patients with multivessel diseaseRisk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgmentChest pain and high-sensitivity troponin: What is the evidence?Pre-analytic variability in cardiovascular biomarker testingQuality markers in cardiology: measures of outcomes and clinical practice--a perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular SurgeryAdjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxarSpontaneous and procedural plaque embolisation in native coronary arteries: pathophysiology, diagnosis, and preventionHigh-sensitivity troponin assays: evidence, indications, and reasonable useRole of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology.Time to shift from contemporary to high-sensitivity cardiac troponin in diagnosis of acute coronary syndromesAssessment and classification of patients with myocardial injury and infarction in clinical practiceBiomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special SituationsAhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese populationEffect of antioxidant supplementation on exercise-induced cardiac troponin release in cyclists: a randomized trialG-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery DiseaseFinnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM CohortCompleteness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort studyIncreased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgeryExpert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failureOxygen therapy for acute myocardial infarction.[Diagnosis of ischemia and revascularization in patients with ventricular tachyarrhythmia].[Myocardial ischemia caused by overuse of headache medications].Validity of a 5-minute focused echocardiography with A-F mnemonic performed by non-echocardiographers in the management of patients with acute chest pain.Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenariosPercutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies.The Impact of Thrombocytopenia on Outcome in Patients with Acute Coronary Syndromes: A Single Center Retrospective Study.Novel biomarkers for cardiovascular risk prediction.Decade-long trends in the magnitude, treatment, and outcomes of patients aged 30 to 54 years hospitalized with ST-segment elevation and non-ST-segment elevation myocardial infarction.Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention.Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarctionClinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population.Local Intracoronary Infusion of Glycoprotein IIb/IIIa Inhibitors via a Perfusion Catheter versus Intracoronary Guiding Catheter Injection during Primary Percutaneous Coronary Intervention: A Pilot Observational StudyLipoprotein-associated phospholipase-A2 activity and its diagnostic potential in patients with acute coronary syndrome and acute ischemic stroke.The diagnostic challenge of myocardial infarction in critically ill patients: do high-sensitivity troponin measurements add more clarity or more confusion?Increased serum cathepsin K in patients with coronary artery disease.Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosisPrognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine
P2860
Q22252969-24D1D08D-7879-476E-BFE3-A3CEF5E987CDQ24186682-95D44697-A529-4455-B932-07D8FDC296C1Q26769732-0D1E668E-93E2-460D-80CF-CFC529FE506AQ26771814-FE182781-2730-4017-B30A-90F4CFF415CDQ26775710-56F67CF5-5DC6-493C-8A9E-87ADE536A913Q26778567-34A38CEC-9F33-49AF-A99B-D40239E6E034Q26801144-D3C30775-F652-4459-BAF3-234A5E5DCA2EQ26828732-C9FF18FC-F8A1-4F8D-8DCF-B6808113C5C3Q27007551-BD9E656F-A5DC-4CCC-A3C3-F0E4AD1EF2A2Q28069234-D08D6A2A-695F-441A-BC57-81C4C81B3B71Q28074647-904BD0A2-628D-487F-838B-1C03A3C6254EQ28078265-53834B15-8399-4419-B1C8-CCD526E00784Q28087152-F364F447-D7F4-4676-BFAD-BFFA49F1ACBBQ28386512-5FFCC2E0-E0F4-4AF2-A33C-F2F800C115B4Q28535273-7DF4CD0F-35BB-417D-8647-8FD383035E97Q28550861-AE73A9CD-60E0-403D-97E4-B7BDA6EEB36CQ28553524-CA7A8274-3FCF-45EF-AE09-698868D4B678Q28660386-16E86663-219A-410F-9AFF-4E0ACC0D1F68Q28817921-F8925D98-5C8D-4972-915B-D367197EFC55Q29994549-5FD21592-8FA9-439C-83CE-B5BED305A38AQ30240009-0CCF2E64-2757-4282-96E1-F12CD2DE6656Q30313114-078600D3-2BA6-4AEE-8E30-35F90EFCC59BQ30317043-C37A0C7C-FFC4-4253-B0C8-F806A97B3C9EQ30415750-80D2FD03-B1D0-4743-A3C9-680943B55C4EQ30449589-DB70AF10-7C37-4BC2-A213-3BFAE424A64FQ30619558-A24B3D96-4CD3-40C2-AA88-003414E5EC8AQ31122441-99C1F63F-2FF8-4853-913E-4A9516C25998Q33427072-B7F214E0-F34F-46A0-B4E4-DC9FF1D5EEB0Q33615459-56E052DF-54DF-4BDC-9AA0-9C5A1BBB6A17Q33648660-EE448590-63CE-489F-8524-92C71260CFD6Q33675980-20F400AF-4924-48F8-B6E4-E0387B8EBCBBQ33687757-4DEB6112-4E48-42DD-B45D-3DFD531BACC6Q33718246-5B0B63D0-DB64-4B14-948F-8BF81D0F6BC8Q33721194-9C37AFB6-17E8-4E4F-BBBD-72E461CCB78EQ33729842-AB2F31FE-C033-4FEC-90D5-1FC6659F5664Q33764961-9FEEA160-FB38-4C10-9BED-696BECADDF6FQ33821925-F0E1ED90-A1F8-4D44-946D-C83E6C1D0067Q33822554-FEB85E60-96E9-4D84-85A1-B77DA795F775Q33836997-8AD28C1A-CCD1-40A9-909C-9ADFAEE31158Q33853247-1DF5D43B-8C99-4D67-8532-EB22E61FB3CC
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Third universal definition of myocardial infarction.
@ast
Third universal definition of myocardial infarction.
@en
Third universal definition of myocardial infarction.
@nl
type
label
Third universal definition of myocardial infarction.
@ast
Third universal definition of myocardial infarction.
@en
Third universal definition of myocardial infarction.
@nl
prefLabel
Third universal definition of myocardial infarction.
@ast
Third universal definition of myocardial infarction.
@en
Third universal definition of myocardial infarction.
@nl
P2093
P2860
P50
P356
P1476
Third universal definition of myocardial infarction.
@en
P2093
Alexander N Parkhomenko
Alfred A Bove
Allan S Jaffe
Barry F Uretsky
Bernard A Chaitman
Bernard R Chaitman
Bertil Lindahl
Christian W Hamm
David A Morrow
P2860
P304
P356
10.1093/EURHEARTJ/EHS184
P50
P577
2012-08-24T00:00:00Z